Delivery Order SPE2DR25D2101-SPE2DR26F47AJ
- Not listed
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Lenvima 18 mg daily dose in a 90-day supply quantity. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for Lenvima 18 mg daily dose, a 90-day supply. The contract is a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs...
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 MG daily dose (60-count supply) on June 18, 2025, with completion targeted for July 11, 2025. This non-set-aside contract represents a direct pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count package. This firm fixed-price delivery order, valued at $10,223.24, is scheduled for completion by August 12, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location. The award was not designated as a set-aside contract and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 20, 2025, for the supply of Lenvima 10 mg daily dose tablets (30-count units) with a ceiling value of $10,773.72. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Lenvima 10 mg daily dose (30-count) with a ceiling value of $10,773.72. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The order is scheduled for completion by December 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose tablets (60-count supply) on January 5, 2026, with completion targeted for January 27, 2026. This firm fixed-price contract represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $10,773.72 to supply Lenvima 10 mg daily dose tablets (30-count) for delivery by January 13, 2026. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, representing a child contract under AmerisourceBergen's larger federal pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for the supply of Lenvima 8 mg daily dose in a 60-tablet quantity. This competitive, firm fixed-price delivery order was executed on January 2, 2026, with an ultimate completion date of January 26, 2026. The contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lenvima (lenvatinib) is a targeted...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47AJDelivery Order
The Defense Logistics Agency awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Lenvima 18 mg daily dose medication in 90-count units. The contract, which is not set-aside and carries an ultimate completion date of January 27, 2026, represents a competitively awarded purchase under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA supply chain. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime contract vehicle extending through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. The IDC authorizes the company to supply a broad spectrum of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency requirements and other federal healthcare customers. The Lenvima delivery represents one of numerous competitively awarded orders placed against this expansive pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 1/4/26 |